{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:26:23Z","timestamp":1789424783309,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sydney Children's Hospital Foundation","award":["Research Grant"],"award-info":[{"award-number":["Research Grant"]}]},{"DOI":"10.13039\/100008714","name":"Motor Neurone Disease Research Institute of Australia","doi-asserted-by":"publisher","award":["152324"],"award-info":[{"award-number":["152324"]}],"id":[{"id":"10.13039\/100008714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40271-020-00415-w","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T02:02:31Z","timestamp":1586311351000},"page":"389-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["\u201cThe Whole Game is Changing and You\u2019ve Got Hope\u201d: Australian Perspectives on Treatment Decision Making in Spinal Muscular Atrophy"],"prefix":"10.1007","volume":"13","author":[{"given":"Michelle A.","family":"Farrar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate A.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Grace","family":"Paguinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine A.","family":"Kasparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"De Abreu Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"issue":"5","key":"415_CR1","doi-asserted-by":"publisher","first-page":"e020907","DOI":"10.1136\/bmjopen-2017-020907","volume":"8","author":"MA Farrar","year":"2018","unstructured":"Farrar MA, Carey KA, Paguinto S-G, Chambers G, Kasparian NA. Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives. BMJ Open. 2018;8(5):e020907.","journal-title":"BMJ Open"},{"issue":"18","key":"415_CR2","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723\u201332.","journal-title":"N Engl J Med."},{"issue":"18","key":"415_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377(18):1713\u201322.","journal-title":"N Engl J Med"},{"issue":"9","key":"415_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jnnp-2017-317412","volume":"89","author":"MA Farrar","year":"2018","unstructured":"Farrar MA, Teoh HL, Carey KA, Cairns A, Forbes R, Herbert K, et al. Nusinersen for SMA: expanded access programme. J Neurol Neurosurg Psychiatry. 2018;89(9):937\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"415_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103\u201315.","journal-title":"Neuromuscul Disord."},{"issue":"3","key":"415_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of Spinal Muscular Atrophy: Part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28(3):197\u2013207.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"415_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s40273-019-00769-6","volume":"37","author":"S Zuluaga-Sanchez","year":"2019","unstructured":"Zuluaga-Sanchez S, Teynor M, Knight C, Thompson R, Lundqvist T, Ekelund M, et al. Cost effectiveness of nusinersen in the treatment of patients with infantile-onset and later-onset spinal muscular atrophy in Sweden. Pharmacoeconomics. 2019;37(6):845\u201365.","journal-title":"Pharmacoeconomics."},{"issue":"1","key":"415_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3233\/JND-190441","volume":"7","author":"A Pechmann","year":"2020","unstructured":"Pechmann A, Baumann M, Bernert G, Flotats-Bastardas M, Gruber-Sedlmayr U, von der Hagen M, et al. Treatment with nusinersen\u2014challenges regarding the indication for children with SMA type 1. J Neuromuscul Dis. 2020;7(1):41\u20136.","journal-title":"J Neuromuscul Dis"},{"issue":"5","key":"415_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.nmd.2017.01.018","volume":"27","author":"F Rouault","year":"2017","unstructured":"Rouault F, Christie-Brown V, Broekgaarden R, Gusset N, Henderson D, Marczuk P, et al. Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients. Neuromuscul Disord. 2017;27(5):428\u201338.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"415_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12883-017-0853-y","volume":"17","author":"S McGraw","year":"2017","unstructured":"McGraw S, Qian Y, Henne J, Jarecki J, Hobby K, Yeh WS. A qualitative study of perceptions of meaningful change in spinal muscular atrophy. BMC Neurol. 2017;17(1):68.","journal-title":"BMC Neurol"},{"issue":"3","key":"415_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ejpn.2019.03.004","volume":"23","author":"E Landfeldt","year":"2019","unstructured":"Landfeldt E, Edstrom J, Sejersen T, Tulinius M, Lochmuller H, Kirschner J. Quality of life of patients with spinal muscular atrophy: a systematic review. Eur J Paediatr Neurol. 2019;23(3):347\u201356.","journal-title":"Eur J Paediatr Neurol."},{"key":"415_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-020-1339-3","volume":"15","author":"HWY Wan","year":"2020","unstructured":"Wan HWY, Carey KA, D\u2019Silva A, Vucic S, Kiernan MC, Kasparian N, et al. Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review. Orphanet J Rare Dis. 2020;15:70.","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"415_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JND-180330","volume":"6","author":"M Pacione","year":"2019","unstructured":"Pacione M, Siskind CE, Day JW, Tabor HK. Perspectives on spinraza (Nusinersen) treatment study: views of individuals and parents of children diagnosed with spinal muscular atrophy. J Neuromuscul Dis. 2019;6(1):119\u201331.","journal-title":"J Neuromuscul Dis"},{"key":"415_CR14","unstructured":"Australian Institute of Health and Welfare. Australia\u2019s Health 2018. Australia\u2019s health series no. 16. AUS 221.2018, Canberra."},{"issue":"Suppl 2","key":"415_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/dmcn.13007","volume":"58","author":"DS Reddihough","year":"2016","unstructured":"Reddihough DS, Meehan E, Stott NS, Delacy MJ. The National Disability Insurance Scheme: a time for real change in Australia. Dev Med Child Neurol. 2016;58(Suppl 2):66\u201370.","journal-title":"Dev Med Child Neurol."},{"key":"415_CR16","volume-title":"Qualitative evaluation and research methods","author":"M Patton","year":"1990","unstructured":"Patton M. Qualitative evaluation and research methods. 2nd ed. London: Sage Publications; 1990.","edition":"2"},{"key":"415_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/104973239500500201","volume-title":"The significance of saturation","author":"JM Morse","year":"1995","unstructured":"Morse JM. The significance of saturation. Thousand Oaks: SAGE Publications Inc; 1995."},{"key":"415_CR18","volume-title":"Qualitative data analysis: a methods sourcebook","author":"MB Miles","year":"2014","unstructured":"Miles MB, Huberman AM, Salda\u00f1a J. Qualitative data analysis: a methods sourcebook. Thousand Oaks: SAGE Publications Inc.; 2014."},{"issue":"3","key":"415_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.24864","volume":"81","author":"MA Farrar","year":"2017","unstructured":"Farrar MA, Park SB, Vucic S, Carey KA, Turner BJ, Gillingwater TH, et al. Emerging therapies and challenges in spinal muscular atrophy. Ann Neurol. 2017;81(3):355\u201368.","journal-title":"Ann Neurol."},{"issue":"6","key":"415_CR20","doi-asserted-by":"publisher","first-page":"e26981","DOI":"10.1002\/pbc.26981","volume":"65","author":"BA Sisk","year":"2018","unstructured":"Sisk BA, Kang TI, Mack JW. Sources of parental hope in pediatric oncology. Pediatr Blood Cancer. 2018;65(6):e26981.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"415_CR21","doi-asserted-by":"publisher","first-page":"e20173549","DOI":"10.1542\/peds.2017-3549","volume":"141","author":"DL Hill","year":"2018","unstructured":"Hill DL, Nathanson PG, Carroll KW, Schall TE, Miller VA, Feudtner C. Changes in parental hopes for seriously ill children. Pediatrics. 2018;141(4):e20173549.","journal-title":"Pediatrics"},{"issue":"11","key":"415_CR22","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1002\/pon.3305","volume":"22","author":"L Granek","year":"2013","unstructured":"Granek L, Barrera M, Shaheed J, Nicholas D, Beaune L, D'Agostino N, et al. Trajectory of parental hope when a child has difficult-to-treat cancer: a prospective qualitative study. Psychooncology. 2013;22(11):2436\u201344.","journal-title":"Psychooncology."},{"issue":"7","key":"415_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625\u201335.","journal-title":"N Engl J Med."},{"issue":"4","key":"415_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1377\/hlthaff.2011.1300","volume":"31","author":"DN Lakdawalla","year":"2012","unstructured":"Lakdawalla DN, Romley JA, Sanchez Y, Maclean JR, Penrod JR, Philipson T. How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies. Health Aff. 2012;31(4):676\u201382.","journal-title":"Health Aff."},{"key":"415_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12883-015-0473-3","volume":"15","author":"Y Qian","year":"2015","unstructured":"Qian Y, McGraw S, Henne J, Jarecki J, Hobby K, Yeh WS. Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study. BMC Neurol. 2015;15:217.","journal-title":"BMC Neurol"},{"issue":"10","key":"415_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/jpc.12386","volume":"49","author":"K Gray","year":"2013","unstructured":"Gray K, Isaacs D, Kilham HA, Tobin B. Spinal muscular atrophy type I: do the benefits of ventilation compensate for its burdens? J Paediatr Child Health. 2013;49(10):807\u201312.","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"415_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamapediatrics.2017.4409","volume":"172","author":"AM Burgart","year":"2017","unstructured":"Burgart AM, Magnus D, Tabor HK, Paquette ED, Frader J, Glover JJ, et al. Ethical challenges confronted when providing nusinersen treatment for spinal muscular atrophy. JAMA Pediatr. 2017;172(2):188\u201392.","journal-title":"JAMA Pediatr."},{"issue":"2","key":"415_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jamapediatrics.2017.4360","volume":"172","author":"V Prasad","year":"2018","unstructured":"Prasad V. Nusinersen for spinal muscular atrophy: Are we paying too much for too little? JAMA Pediatr. 2018;172(2):123\u20135.","journal-title":"JAMA Pediatr"},{"issue":"6","key":"415_CR29","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/ajmg.a.38220","volume":"173","author":"FK Boardman","year":"2017","unstructured":"Boardman FK, Young PJ, Griffiths FE. Newborn screening for spinal muscular atrophy: the views of affected families and adults. Am J Med Genet A. 2017;173(6):1546\u201361.","journal-title":"Am J Med Genet A."},{"issue":"2","key":"415_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ajmg.a.38031","volume":"173","author":"FK Boardman","year":"2017","unstructured":"Boardman FK, Young PJ, Griffiths FE. Population screening for spinal muscular atrophy: a mixed methods study of the views of affected families. Am J Med Genet A. 2017;173(2):421\u201334.","journal-title":"Am J Med Genet A."},{"issue":"1","key":"415_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/hex.12602","volume":"21","author":"FK Boardman","year":"2018","unstructured":"Boardman FK, Young PJ, Warren O, Griffiths FE. The role of experiential knowledge within attitudes towards genetic carrier screening: a comparison of people with and without experience of spinal muscular atrophy. Health Expect. 2018;21(1):201\u201311.","journal-title":"Health Expect"},{"issue":"4","key":"415_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5694\/mja17.00772","volume":"209","author":"H Sampaio","year":"2018","unstructured":"Sampaio H, Wilcken B, Farrar M. Screening for spinal muscular atrophy. Med J Aust. 2018;209(4):147\u20138.","journal-title":"Med J Aust."},{"issue":"11","key":"415_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/0883073817716853","volume":"32","author":"DV Murrell","year":"2017","unstructured":"Murrell DV, Lotze TE, Farber HJ, Crawford CA, Wiemann CM. The experience of families with children with spinal muscular atrophy type I across health care systems. J Child Neurol. 2017;32(11):917\u201323.","journal-title":"J Child Neurol."},{"issue":"1","key":"415_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1056\/NEJMp1209500","volume":"368","author":"LE Oshima","year":"2013","unstructured":"Oshima LE, Emanuel EJ. Shared decision making to improve care and reduce costs. N Engl J Med. 2013;368(1):6\u20138.","journal-title":"N Engl J Med."},{"key":"415_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jpeds.2017.09.001","volume":"192","author":"JL Lin","year":"2018","unstructured":"Lin JL, Cohen E, Sanders LM. Shared decision making among children with medical complexity: results from a population-based survey. J Pediatr. 2018;192:216\u201322.","journal-title":"J Pediatr"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-020-00415-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40271-020-00415-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-020-00415-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T23:23:44Z","timestamp":1617837824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40271-020-00415-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s40271-020-00415-w","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]},"assertion":[{"value":"8 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Support for this research was provided by a Sydney Children\u2019s Hospital Foundation research Grant. The funding source did not have a role in the study design, collection, analysis, and interpretation of the data, in the writing of the article, or in the decision to submit it for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Associate Professor Farrar has served on the scientific advisory board for Biogen and received grant support from the Motor Neurone Diseases Research Institute of Australia Beryl Bayley MND Postdoctoral Fellowship (152324). Professor Kasparian is the recipient of a National Heart Foundation of Australia Future Leader Fellowship (101229) and a 2018\u20132019 Harkness Fellowship in Health Care Policy and Practice from the Commonwealth Fund. Dr Carey, Ms Paguinto and Associate Professor De Abreu Louren\u00e7o have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the principles of the 1964 Declaration of Helsinki and its later amendments. The institutional review boards, the Sydney Children\u2019s Hospitals Network Human Research Ethics Committee and the University of Technology Sydney Human Research Ethics Committee approved the study (HREC\/17\/SCHN\/227, ETH17-1967).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent to participate in the focus groups and for the coded data of their focus groups to be used for analysis and submitted for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The data are not publicly available because they contain information that could compromise interviewees\u2019 privacy and consent.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}